Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Monetizing social media is a great way to earn cash. Explore various strategies to turn your online presence into profit.
21,134 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
SAP's chief executive says the AI race is being fought in the wrong place, stressing execution and operational contex...
Institutional investors are loading up on two beaten-down software giants as AI infrastructure demand remains solid a...
A Colorado resident was drawn into a high-pressure sales pitch for a $1 million fixed indexed annuity, featuring a ph...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
As AI workloads surge, choosing the right infrastructure partner matters. This guide compares CoreWeave and Nebius, w...
Investors debate whether will joby aviation stock can double in 2026 as the eVTOL pioneer nears regulatory milestones...
A rival’s blowout earnings stirred optimism across hardware names. This piece breaks down why super micro computer st...
Two different growth paths—mega-cap stability and nimble small-cap momentum. Learn how to balance an 'owns blue chips...
As volatility persists in 2026, savvy investors are exploring the tax advantages of placing Main Street Capital in a ...
After a year of catalyst-driven hopes, XRP’s price hasn’t followed suit. This article lays out a practical framework ...
AMD beats just 2030’s earnings target two years ahead as AI-driven data center growth accelerates. Here's what it mea...